FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079374922> ?p ?o ?g. }

• W2079374922 abstract "Abstract Background ErbB3-binding protein 1 (Ebp1) is a member of the PA2G4 family of proliferation-regulated proteins that is expressed in multiple malignant and non-malignant cells. ErbB3 and other members of the EGFR family have been implicated in cancer progression, it however remains unknown whether Ebp1 participate in prostate cancer progression in vivo . Therefore, the present study examines Ebp1 expression in cancerous and non-cancerous prostates tissues. Ebp1 expression was also correlated to known Ebp1 regulated proteins (Androgen receptor (AR), Cyclin D1 & ErbB3) and the proliferation marker Ki67. Furthermore we evaluated whether Ebp1 expression correlated with biochemical recurrence (BCR) following radical prostatectomy. Methods The expression of Ebp1, AR, Cyclin D1, ErbB3 and Ki67 were evaluated by immunohistochemistry using three separate tissue micro-arrays containing normal prostate tissues, non-cancerous tissue adjacent to the primary tumor, hormone-sensitive and hormone-refractory cancerous tissues. Multivariate COX regression analysis was performed with four clinical parameters in order to correlate Ebp1 expression with PCa progression. Results The expression of Ebp1 significantly increased with the progression from normal to hormone sensitive and to hormone refractory PCa. Furthermore, we observed strong correlation between Ebp1 expression and the nuclear expression of AR, Cyclin D1 and ErbB3 in both normal adjacent and cancer tissues. The expression of AR, Cyclin D1 and ErbB3 in normal adjacent tissues correlated with PSA relapse, whereas Ebp1 on its own did not significantly predict PSA relapse. Finally, in a multivariate analysis with a base clinical model (Gleason, Pre-op PSA, surgical margins and P-stage) we identified the multi-marker combination of Ebp1+/Cyclin D1- as an independent predictor of PSA relapse with a hazard ratio of 4.79. Conclusion Although not related to disease recurrence, this is the first in vivo study to report that Ebp1 expression correlates with PCa progression." @default.
• W2079374922 created "2016-06-24" @default.
• W2079374922 creator A5005580505 @default.
• W2079374922 creator A5044228660 @default.
• W2079374922 creator A5052794976 @default.
• W2079374922 creator A5053749991 @default.
• W2079374922 creator A5070217428 @default.
• W2079374922 creator A5079616480 @default.
• W2079374922 date "2008-11-24" @default.
• W2079374922 modified "2023-10-14" @default.
• W2079374922 title "Ebp1 expression in benign and malignant prostate" @default.
• W2079374922 cites W1510939964 @default.
• W2079374922 cites W1520173732 @default.
• W2079374922 cites W1661202104 @default.
• W2079374922 cites W1965734230 @default.
• W2079374922 cites W1966268953 @default.
• W2079374922 cites W1972066250 @default.
• W2079374922 cites W1981633345 @default.
• W2079374922 cites W2003852222 @default.
• W2079374922 cites W2004555158 @default.
• W2079374922 cites W2016235567 @default.
• W2079374922 cites W2031395328 @default.
• W2079374922 cites W2036902495 @default.
• W2079374922 cites W2071879495 @default.
• W2079374922 cites W2072065814 @default.
• W2079374922 cites W2074003741 @default.
• W2079374922 cites W2096522691 @default.
• W2079374922 cites W2097664337 @default.
• W2079374922 cites W2101598816 @default.
• W2079374922 cites W2102807020 @default.
• W2079374922 cites W2105882193 @default.
• W2079374922 cites W2116205673 @default.
• W2079374922 cites W2123559875 @default.
• W2079374922 cites W2125787669 @default.
• W2079374922 cites W2136094622 @default.
• W2079374922 cites W2139550077 @default.
• W2079374922 cites W2147010946 @default.
• W2079374922 cites W2154176338 @default.
• W2079374922 cites W2161298201 @default.
• W2079374922 cites W2164485366 @default.
• W2079374922 cites W2169909508 @default.
• W2079374922 cites W2315492970 @default.
• W2079374922 cites W3023689102 @default.
• W2079374922 cites W4295773257 @default.
• W2079374922 doi "https://doi.org/10.1186/1475-2867-8-18" @default.
• W2079374922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2614409" @default.
• W2079374922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19025630" @default.
• W2079374922 hasPublicationYear "2008" @default.
• W2079374922 type Work @default.
• W2079374922 sameAs 2079374922 @default.
• W2079374922 citedByCount "16" @default.
• W2079374922 countsByYear W20793749222012 @default.
• W2079374922 countsByYear W20793749222014 @default.
• W2079374922 countsByYear W20793749222015 @default.
• W2079374922 countsByYear W20793749222017 @default.
• W2079374922 countsByYear W20793749222018 @default.
• W2079374922 countsByYear W20793749222020 @default.
• W2079374922 countsByYear W20793749222023 @default.
• W2079374922 crossrefType "journal-article" @default.
• W2079374922 hasAuthorship W2079374922A5005580505 @default.
• W2079374922 hasAuthorship W2079374922A5044228660 @default.
• W2079374922 hasAuthorship W2079374922A5052794976 @default.
• W2079374922 hasAuthorship W2079374922A5053749991 @default.
• W2079374922 hasAuthorship W2079374922A5070217428 @default.
• W2079374922 hasAuthorship W2079374922A5079616480 @default.
• W2079374922 hasBestOaLocation W20793749221 @default.
• W2079374922 hasConcept C115456853 @default.
• W2079374922 hasConcept C121608353 @default.
• W2079374922 hasConcept C126322002 @default.
• W2079374922 hasConcept C142724271 @default.
• W2079374922 hasConcept C143998085 @default.
• W2079374922 hasConcept C199835354 @default.
• W2079374922 hasConcept C204232928 @default.
• W2079374922 hasConcept C2776235491 @default.
• W2079374922 hasConcept C2777008409 @default.
• W2079374922 hasConcept C2779256057 @default.
• W2079374922 hasConcept C2779438470 @default.
• W2079374922 hasConcept C2779466945 @default.
• W2079374922 hasConcept C2780192828 @default.
• W2079374922 hasConcept C29537977 @default.
• W2079374922 hasConcept C502942594 @default.
• W2079374922 hasConcept C61367390 @default.
• W2079374922 hasConcept C71924100 @default.
• W2079374922 hasConceptScore W2079374922C115456853 @default.
• W2079374922 hasConceptScore W2079374922C121608353 @default.
• W2079374922 hasConceptScore W2079374922C126322002 @default.
• W2079374922 hasConceptScore W2079374922C142724271 @default.
• W2079374922 hasConceptScore W2079374922C143998085 @default.
• W2079374922 hasConceptScore W2079374922C199835354 @default.
• W2079374922 hasConceptScore W2079374922C204232928 @default.
• W2079374922 hasConceptScore W2079374922C2776235491 @default.
• W2079374922 hasConceptScore W2079374922C2777008409 @default.
• W2079374922 hasConceptScore W2079374922C2779256057 @default.
• W2079374922 hasConceptScore W2079374922C2779438470 @default.
• W2079374922 hasConceptScore W2079374922C2779466945 @default.
• W2079374922 hasConceptScore W2079374922C2780192828 @default.
• W2079374922 hasConceptScore W2079374922C29537977 @default.
• W2079374922 hasConceptScore W2079374922C502942594 @default.
• W2079374922 hasConceptScore W2079374922C61367390 @default.
• W2079374922 hasConceptScore W2079374922C71924100 @default.

• next